Procurement Summary
Country : Brazil
Summary : Acquisition of Regular Drugs. (Process: 25410.010861/2024-81)
Deadline : 02 Jun 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 119496745
Document Ref. No. : 91088/2025
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of regular drugs. (Process: 25410.010861/2024-81)
UASG Code: 250052
Notice from: 05/20/2025 from 09:00 to 16:00 hs
Proposal delivery: from 05/20/2025 to 09:00
ampicillin, composition associated with sulbactam, concentration 2G + 1 g, pharmaceutical form powder for injectable solution
Quantity: 170391
ampicillin, composition associated with sulbactam, concentration 2 g + 1 g, pharmaceutical form for injectable solution
quantity: 7099
trioxide of arsenic, concentration 1 mg/ ml, pharmaceutical form for perfusion
quantity: quantity: quantity: quantity210
Aztreonam, concentration 1 g, pharmaceutical form powder for injectable solution
Quantity: 2925
aztreonam, concentration 1 g, pharmaceutical form for injectable solution
quantity: 975
ceptazidima, composition associated with avibactam, 2000 mg + 500 mg composition
quantity: 6624
ceptazidima, composition associated with avibactam, concentration 2000 mg + 500 mg, injectable pharmaceutical form
Quantity: 96
ceptolozana, composition associated with tazobactam, concentration 1 g + 0.5g, pharmaceutical form liophile powder for injectable + diluent
quantity: 5670
surgical sealant, surgicalComposition 1 fibrinogen, aprotinin, thrombin, composition2 calcium chloride, pharmaceutical form 1 topical solution, additional characteristics w/ application set, total volume 4 ml
quantity: 930
sodium phosphate, enema presentation, 16% + phosphatodic phosphate dosage 6%
: 10950
glycerol, dosage 12%, presentation clister
quantity: 9788
glycerol, dosage 12%, presentation clister
quantity: 3262
infliximab, dosage 100 mg, pharmaceutical form liophilic powder for injectable
quantity
quantity, concentration 100 mg
quantity: 4650
isavuconazone, concentration200 mg, pharmaceutical form Liofilo powder for injectable br...
Documents
Tender Notice